By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Nereus Pharmaceuticals, Inc. 

10480 Wateridge Circle

San Diego  California  92121  U.S.A.
Phone: 858-587-4090 Fax: 858-587-4088


SEARCH JOBS


Industry
Pharmaceutical






Company News
Nereus Pharmaceuticals, Inc. Raises $20 Million 6/23/2010 7:26:09 AM
Nereus Pharmaceuticals, Inc. Completes Enrollment of Phase 2 ADVANCE Clinical Trial of Plinabulin in Non-Small Cell Lung Cancer 6/22/2010 8:48:47 AM
Nereus Pharmaceuticals, Inc. Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conference 11/23/2009 9:52:24 AM
Nereus Pharmaceuticals, Inc. Initiates ADVANCE, a Randomized Phase 2 Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer 3/23/2009 8:34:37 AM
Nereus Pharmaceuticals, Inc. Initiates Combination Clinical Trial for Proteasome Inhibitor NPI-0052 in Solid Tumors 4/18/2008 8:44:52 AM
Nereus Pharmaceuticals, Inc. Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data 3/20/2008 6:43:56 AM
Nereus Pharmaceuticals, Inc.'s NPI-0052 Named One of the Industry's Top Ten Unpartnered Oncology Drug Candidates 10/16/2007 8:17:55 AM
Nereus Pharmaceuticals, Inc. Raises $45 Million in Series D-2 Financing 8/9/2007 7:36:29 AM
The Multiple Myeloma Research Consortium and Nereus Pharmaceuticals, Inc. Initiate Clinical Trial Investigating NPI-0052 to Treat Multiple Myeloma 4/16/2007 11:44:26 AM
Nereus Pharmaceuticals, Inc. to Present Data at the American Association for Cancer Research 2007 Annual Meeting 4/9/2007 1:40:45 PM
12
//-->